EV Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '17 Dec 31, 2017	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014
Operating Revenue	9.47	9.51	42.64	46.23	44.46
Other Revenue	0	-	-	-	-
Revenue	9.47	9.51	42.64	46.23	44.46
Revenue Growth (YoY)	-0.34%	-77.71%	-7.76%	3.99%	4.65%
Cost of Revenue	7.94	7.61	26.17	29.36	27.5
Gross Profit	1.54	1.9	16.48	16.87	16.95
Selling, General & Admin	1.38	5.83	13.29	4.01	1.74
Operating Expenses	1.38	5.83	13.29	4.01	1.74
Operating Income	0.15	-3.93	3.19	12.86	15.22
Interest Expense	-0.58	-0.66	-1.03	-1.3	-1.18
Interest & Investment Income	-	0.07	0.11	0.07	0.02
Currency Exchange Gain (Loss)	-	-	-0.01	-	-
Other Non Operating Income (Expenses)	-0.1	0.07	0.59	-0.05	-0.1
EBT Excluding Unusual Items	-0.52	-4.46	2.85	11.58	13.95
Asset Writedown	-	-1.91	-52.69	-	-
Other Unusual Items	-	-0.79	-	-	-
Pretax Income	-0.52	-7.16	-49.83	11.58	13.95
Income Tax Expense	0.03	0.27	3.36	2.9	3.26
Net Income	-0.55	-7.43	-53.19	8.68	10.69
Net Income to Common	-0.55	-7.43	-53.19	8.68	10.69
Net Income Growth	-	-	-	-18.82%	6.40%
Shares Outstanding (Basic)	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2
Shares Change (YoY)	-	1.02%	49.09%	-	-
EPS (Basic)	-0.23	-3.08	-22.30	5.42	6.68
EPS (Diluted)	-0.23	-3.08	-22.30	5.42	6.68
EPS Growth	-	-	-	-18.82%	6.40%
Free Cash Flow	-	-0.38	-23.34	4.19	11.27
Free Cash Flow Per Share	-	-0.16	-9.79	2.62	7.04
Gross Margin	16.24%	19.94%	38.64%	36.49%	38.13%
Operating Margin	1.64%	-41.34%	7.47%	27.81%	34.23%
Profit Margin	-5.82%	-78.15%	-124.73%	18.77%	24.05%
Free Cash Flow Margin	-	-3.99%	-54.74%	9.05%	25.35%
EBITDA	-	-3.24	5.4	14.61	16.6
EBITDA Margin	-	-34.11%	12.67%	31.61%	37.35%
D&A For EBITDA	-	0.69	2.22	1.75	1.39
EBIT	0.15	-3.93	3.19	12.86	15.22
EBIT Margin	1.64%	-41.34%	7.47%	27.81%	34.23%
Effective Tax Rate	-	-	-	25.03%	23.36%
Revenue as Reported	9.47	9.51	42.64	46.23	44.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.